Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
AZD8186
i
Other names:
AZD8186
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
AstraZeneca
Drug class:
PI3Kβ inhibitor
Related drugs:
‹
GSK2636771 (8)
AZD6482 (2)
TGX-221 (1)
CVL237 (0)
GS-9820 (0)
GSK2636771 (8)
AZD6482 (2)
TGX-221 (1)
CVL237 (0)
GS-9820 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
PTEN deletion
Gastric Cancer
PTEN deletion
Gastric Cancer
AZD8186
Sensitive: C2 – Inclusion Criteria
AZD8186
Sensitive
:
C2
AZD8186
Sensitive: C2 – Inclusion Criteria
AZD8186
Sensitive
:
C2
PIK3CB mutation
Gastric Cancer
PIK3CB mutation
Gastric Cancer
AZD8186
Sensitive: C3 – Early Trials
AZD8186
Sensitive
:
C3
AZD8186
Sensitive: C3 – Early Trials
AZD8186
Sensitive
:
C3
PTEN deletion
Triple Negative Breast Cancer
PTEN deletion
Triple Negative Breast Cancer
AZD8186
Sensitive: D – Preclinical
AZD8186
Sensitive
:
D
AZD8186
Sensitive: D – Preclinical
AZD8186
Sensitive
:
D
KRAS mutation
Pancreatic Cancer
KRAS mutation
Pancreatic Cancer
SCH772984 + AZD8186
Sensitive: D – Preclinical
SCH772984 + AZD8186
Sensitive
:
D
SCH772984 + AZD8186
Sensitive: D – Preclinical
SCH772984 + AZD8186
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login